Defining asthma control
How do patient perceptions of asthma control differ from guideline definitions?
This browser is no longer supported.
To provide you with the best possible experience, we kindly ask you to switch to a supported browser:
Anoro Ellipta 20 mcg
has been added to your basket
Improving asthma control has a direct impact on the quality of life of patients, helping them return to doing the things they love to do.
When measured using the Asthma Quality of Life Questionnaire (AQLQ), 27% more patients improved their quality of life vs other commonly used ICS/LABAs in everyday practice.*1
Oscar’s asthma was uncontrolled, with frequent day-time symptoms, activity limitation, and a high reliance on his SABA reliever. With Relvar, Oscar’s quality of life has improved compared to what it was like with his old treatment,1 meaning he’s back to playing football actively again!
According to GINA, one of the key indicators of poor asthma control is experiencing night-time symptoms.4 For many patients, this parameter may also impact their quality of life.
In an analysis of three studies comparing Relvar to placebo, fluticasone furoate (FF), and fluticasone propionate (FP) respectively, a higher percentage of patients experienced symptom-free nights with Relvar in all instances.5
As a partially controlled asthma patient, Paula was frequently waking during the night. Now, with the help of Relvar, she is sleeping through the night more often than she was with her old treatment,5 letting her more frequently wake up fresh in the mornings!
From educational videos to podcasts, Breathing Space is a GSK initiative designed to share the latest thinking on lung health and provide a space for pulmonologists and other respiratory specialists to gather insights and explore best practice.